Aristo first-half profit rises 18% despite 23% revenue fall
Key highlights
- Aristo reported net profit of Rs 4.9019 crore for the September 2026 half year, up 18% year on year.
- Aristo's revenue from operations declined 23% to Rs 198.2417 crore in the six months ended September 30, 2026.
- Aristo's total expenses fell 24% to Rs 191.8028 crore, compared with Rs 250.9948 crore a year earlier.
- Aristo's trade receivables rose to Rs 113.8399 crore at September 30, 2026, from Rs 54.7269 crore at March 31, 2026.
powered by IRIS

Aristo Bio-Tech and Lifescience Limited reported net profit of Rs 4.9019 crore for the six months ended September 30, 2026, up 18% from Rs 4.1696 crore a year earlier, despite a 23% fall in revenue from operations to Rs 198.2417 crore. The unaudited standalone results were approved by the board on November 14, 2026.
Know Aristo Bio-Tech & Lifescience inside out
Results, valuation, peers and who's buying, in one view.
What did Aristo report for the September 2026 half year?
Aristo reported total revenue of Rs 198.4011 crore for the six months ended September 30, 2026, down from Rs 256.5393 crore in the six months ended September 30, 2025. Revenue from operations was Rs 198.2417 crore, while other income was Rs 15.94 lakh. In the prior-year half, operating revenue was Rs 256.4531 crore and other income was Rs 8.61 lakh.
Profit before tax rose to Rs 6.5984 crore from Rs 5.5444 crore, while tax expense increased to Rs 1.6965 crore from Rs 1.3749 crore. Net profit consequently increased by Rs 73.23 lakh to Rs 4.9019 crore. Basic and diluted earnings per share were Rs 7.20 each, compared with Rs 6.12 each a year earlier, on paid-up equity share capital of Rs 6.8078 crore.
Why did Aristo's profit rise while revenue declined?
Aristo's profit before tax rose because total expenses declined by Rs 59.1920 crore, slightly more than the Rs 58.1382 crore decline in total revenue. Total expenses were Rs 191.8028 crore in the September 2026 half year, compared with Rs 250.9948 crore in the corresponding 2025 period. The difference between total revenue and expenses therefore increased to Rs 6.5984 crore from Rs 5.5444 crore.
Cost of materials consumed, Aristo's largest expense, declined to Rs 177.8733 crore from Rs 239.4168 crore, a reduction of Rs 61.5435 crore. Other expenses fell to Rs 5.9422 crore from Rs 6.7330 crore, while employee-benefit expense increased to Rs 2.3633 crore from Rs 2.1701 crore. Finance cost rose to Rs 1.7557 crore from Rs 97.76 lakh, and depreciation and amortisation increased to Rs 1.5733 crore from Rs 1.4666 crore.
Aristo recorded Rs 2.2949 crore as the expense for changes in inventories of finished goods, work in progress and stock-in-trade, compared with Rs 23.08 lakh in the prior-year half. The filing shows no exceptional or extraordinary items for either half year. The increase in profit before tax therefore came through the ordinary revenue and expense lines reported in the standalone statement.
How did Aristo's profitability compare with earlier periods?
Aristo's net profit was about 2.5% of total revenue in the six months ended September 30, 2026, compared with about 1.6% in the corresponding 2025 period, based on the reported figures. Profit before tax was about 3.3% of total revenue, compared with about 2.2% a year earlier. These calculations reflect the faster reduction in expenses than in revenue.
Aristo also reported a larger result than in the immediately preceding six months ended March 31, 2026. Revenue from operations was Rs 107.2640 crore in that period, net profit was Rs 3.0131 crore and profit before tax was Rs 4.1532 crore. The March 2026 half covers October 1, 2025 to March 31, 2026, while the latest half covers April 1, 2026 to September 30, 2026.
Got a follow-up? Ask IRIS
What business and accounting basis do Aristo's results cover?
Aristo says it provides manufacturing, formulation, supply, packaging and job-work services for pesticides and agrochemicals, including insecticides, herbicides, fungicides and plant growth regulators. The company says these activities serve Indian and export markets. It reported one business segment, so the filing does not provide revenue, profit or asset data by product category or geography.
The September 2026 result is an unaudited standalone statement prepared under Indian Generally Accepted Accounting Principles and Accounting Standards specified under Section 133 of the Companies Act, 2013. Aristo says Indian Accounting Standards, known as Ind AS, are not currently applicable to it. Its Rs 7.20 earnings per share figure is calculated using weighted-average share capital, and each equity share has a face value of Rs 10.
The statutory auditor, Prakash Chandra Jain & Co., conducted a limited review of the September 30, 2026 statement. The auditor said nothing had come to its attention that caused it to believe the statement did not disclose information required by the applicable listing rules or contained a material misstatement. The report also says a limited review is substantially narrower than an audit and does not result in an audit opinion.
What working-capital and cash-flow movements accompanied the result?
Aristo reported total assets and total equity and liabilities of Rs 188.9544 crore at September 30, 2026, compared with Rs 155.2159 crore at March 31, 2026. Trade receivables rose to Rs 113.8399 crore from Rs 54.7269 crore, while inventories declined to Rs 34.2037 crore from Rs 63.2101 crore. Cash and cash equivalents were Rs 2.5465 crore at September 30, compared with Rs 2.6265 crore at March 31.
Net cash flow from operating activities was Rs 2.4151 crore for the six months ended September 30, 2026. The cash-flow statement records a Rs 59.1131 crore increase in trade receivables and a Rs 29.0063 crore inventory movement, alongside a Rs 25.5127 crore increase in trade payables. Investing activities used Rs 1.1178 crore and financing activities used Rs 1.3773 crore, resulting in an Rs 8 lakh fall in cash and cash equivalents.
Short-term borrowings increased to Rs 28.8088 crore at September 30 from Rs 27.7672 crore at March 31, while long-term borrowings rose to Rs 7.7725 crore from Rs 7.6314 crore. Creditors other than micro and small enterprises increased to Rs 90.7204 crore from Rs 64.9020 crore. Aristo reported contingent liabilities of Rs 18.22 lakh and said no investor complaints were received or pending as of September 30, 2026.
Conclusion
Aristo's September 2026 half-year result combined a 23% decline in operating revenue with an 18% rise in net profit because the Rs 59.1920 crore reduction in total expenses exceeded the Rs 58.1382 crore decrease in total revenue. Lower material consumption was the largest reported cost movement, while the company also delivered higher profit before tax and earnings per share than in the prior-year half.
The filing provides no management revenue target, earnings guidance or scheduled next-results date. The next disclosure will be relevant for changes in the Rs 113.8399 crore receivables balance, operating cash flow of Rs 2.4151 crore and contingent liabilities of Rs 18.22 lakh, which include bank guarantees, contracts to be executed and sales-tax demands not considered debt.


